BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs6983267
,
FGF21
,
G-protein-coupled receptor binding
,
Obesity
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
evista
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
Evista patents upheld.
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evist…
Pharmacokinetics of selective estrogen receptor modulators(SERMs).
Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
EVA: Evista Alendronate Comparison
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain …
Raloxifene and Rimostil for Perimenopause-Related Depression
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ